Uncategorized
Inflammasome Therapeutics’ Kamuvudines May Be Answer to Preventing Blindness in Aging Population
NEWTON, Mass.--(BUSINESS WIRE)-- #AMD--Inflammasome Therapeutics' Kamuvudines may be answer to preventing blindness in aging population. Research published last week points to potential.